With just weeks until the No Surprises Act goes into effect a final ruling by the Biden Administration has some parties – including 152 doctors in Congress – crying foul. What does the final ruling mean and how does the Biden rule affect the spirit and letter of the law? We take a look at these late breaking changes in this week’s news roundup.
152 Doctors in Congress Pushback on Biden Ruling on No Surprises Act
In a rare bipartisan moment, 152 doctors in Congress spoke out against the Biden ruling on the arbitration portion of the No Surprises Act. According to the letter of complaint, the ruling cuts the patient out of the arbitration process leaving the payers and providers to negotiate the fee that is owed. What concerns the bipartisan group of doctors is that this will still leave patients, particularly underserved patients, vulnerable to higher charges and lack of choice.
You can read the full story on NPR.
Podcast: Understanding Reasonable and Acceptable Reimbursements for Payers
The No Surprises Act is causing no end of confusion for both healthcare payers and providers. As the story above outlined arbitration is one common cause for concern, but what if payers could avoid going to arbitration in the first place, by ensuring reasonable and acceptable reimbursements were in place. In a recent podcast on Future Healthcare Today, industry expert, Greg Hackett joined host, Kevin Tierney, to discuss what constitutes reasonable and acceptable reimbursement to avoid disputes, or at least ease the independent dispute resolution (IDR) experience for payers.
You can listen to the full podcast here.
Price Transparency: Compliance Mandate or Strategic Investment?
While there’s push back from some quarters on the No Surprises Act because of the headaches is causing with only a year to implement, David Vivero, sees things differently. Vivero, the CEO of Amnio sees the No Surprises Act as an opportunity to make strategic investments that will set payers and providers on the right course for the future. In a recent article on Future Healthcare Today, Vivero shared that: “these regulations present a unique opportunity for payer organizations to gain a competitive edge by leveraging a substantial market shift to guide strategic investments and improvements.”
Want to read more of what Vivero has to say? You can do that here.